Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
123 Investment Managers (formerly 123Ventures) is a leading French independent private equity and venture capital firm based in Paris. Founded in 2001, the firm specializes in providing growth capital and buyout financing to small and medium-sized enterprises (SMEs) across Europe, with a significant focus on the healthcare, tourism, and real estate sectors. In the healthcare space, 123 IM is a major investor in the pharmacy sector and elderly care facilities (EHPAD), while also maintaining a historical portfolio of innovative biotechnology and medical technology companies. The firm has historically backed life science companies such as Nautilus Biotech, Novagali Pharma, and Auris Medical, and continues to manage a diverse portfolio of healthcare-related assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 123 Ventures.